Hirokuni Takano

14PUBLICATIONS
107CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisHaematological tumoursTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 25, 2026
A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101).

|Jul 25, 2026
Outcome of advanced ovarian cancer patients who do not undergo cytoreductive surgery in the era of PARP inhibitors maintenance therapy: a propensity score-based analysis.

|Jul 23, 2026
Ureteral Metastasis From Endometrial Carcinoma Mimicking Upper Tract Urothelial Carcinoma.

|Nov 07, 2025
Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients.

Satoshi Yanagida, Yuichi Shoburu, Takako Kiyokawa

|Jul 01, 2025
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.

Shin Nishio, Tadaaki Nishikawa, Masahiko Mori

|Mar 28, 2025
Bevacizumab in frontline chemotherapy improved the survival outcome for advanced ovarian clear cell carcinoma: a multicenter retrospective analysis.

Shinichi Tate, Toshiyuki Seki, Kyoko Nishikimi

Pageof 3

Frequent Collaborators

9 joint publications

Aikou Okamoto

5 joint publications

Motoaki Saito

4 joint publications

Hiroshi Tanabe

4 joint publications

Kyosuke Yamada